233 related articles for article (PubMed ID: 23230269)
1. Comparison of genome-wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional and local suppression of promyogenic transcription factors.
MacQuarrie KL; Yao Z; Fong AP; Diede SJ; Rudzinski ER; Hawkins DS; Tapscott SJ
Mol Cell Biol; 2013 Feb; 33(4):773-84. PubMed ID: 23230269
[TBL] [Abstract][Full Text] [Related]
2. The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation.
Marchesi I; Fiorentino FP; Rizzolio F; Giordano A; Bagella L
Cell Cycle; 2012 Oct; 11(20):3828-36. PubMed ID: 22983009
[TBL] [Abstract][Full Text] [Related]
3. Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding.
Li S; Chen K; Zhang Y; Barnes SD; Jaichander P; Zheng Y; Hassan M; Malladi VS; Skapek SX; Xu L; Bassel-Duby R; Olson EN; Liu N
Genes Dev; 2019 Jun; 33(11-12):626-640. PubMed ID: 30975722
[TBL] [Abstract][Full Text] [Related]
4. The transcriptional co-repressor TLE3 regulates myogenic differentiation by repressing the activity of the MyoD transcription factor.
Kokabu S; Nakatomi C; Matsubara T; Ono Y; Addison WN; Lowery JW; Urata M; Hudnall AM; Hitomi S; Nakatomi M; Sato T; Osawa K; Yoda T; Rosen V; Jimi E
J Biol Chem; 2017 Aug; 292(31):12885-12894. PubMed ID: 28607151
[TBL] [Abstract][Full Text] [Related]
5. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis.
Tapscott SJ; Thayer MJ; Weintraub H
Science; 1993 Mar; 259(5100):1450-3. PubMed ID: 8383879
[TBL] [Abstract][Full Text] [Related]
6. Actin-related protein 5 functions as a novel modulator of MyoD and MyoG in skeletal muscle and in rhabdomyosarcoma.
Morita T; Hayashi K
Elife; 2022 Mar; 11():. PubMed ID: 35348112
[TBL] [Abstract][Full Text] [Related]
7. Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD.
Knudsen ES; Pazzagli C; Born TL; Bertolaet BL; Knudsen KE; Arden KC; Henry RR; Feramisco JR
Cancer Res; 1998 May; 58(9):2042-9. PubMed ID: 9581851
[TBL] [Abstract][Full Text] [Related]
8. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.
Pomella S; Sreenivas P; Gryder BE; Wang L; Milewski D; Cassandri M; Baxi K; Hensch NR; Carcarino E; Song Y; Chou HC; Yohe ME; Stanton BZ; Amadio B; Caruana I; De Stefanis C; De Vito R; Locatelli F; Chen Y; Chen EY; Houghton P; Khan J; Rota R; Ignatius MS
Nat Commun; 2021 Jan; 12(1):192. PubMed ID: 33420019
[TBL] [Abstract][Full Text] [Related]
9. Sharp-1/DEC2 inhibits skeletal muscle differentiation through repression of myogenic transcription factors.
Azmi S; Ozog A; Taneja R
J Biol Chem; 2004 Dec; 279(50):52643-52. PubMed ID: 15448136
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide binding of the basic helix-loop-helix myogenic inhibitor musculin has substantial overlap with MyoD: implications for buffering activity.
MacQuarrie KL; Yao Z; Fong AP; Tapscott SJ
Skelet Muscle; 2013 Nov; 3(1):26. PubMed ID: 24175993
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming.
Cao Y; Yao Z; Sarkar D; Lawrence M; Sanchez GJ; Parker MH; MacQuarrie KL; Davison J; Morgan MT; Ruzzo WL; Gentleman RC; Tapscott SJ
Dev Cell; 2010 Apr; 18(4):662-74. PubMed ID: 20412780
[TBL] [Abstract][Full Text] [Related]
12. The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of myoD.
Lemercier C; To RQ; Carrasco RA; Konieczny SF
EMBO J; 1998 Mar; 17(5):1412-22. PubMed ID: 9482738
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.
Chen B; He L; Savell VH; Jenkins JJ; Parham DM
Cancer Res; 2000 Jun; 60(12):3290-8. PubMed ID: 10866323
[TBL] [Abstract][Full Text] [Related]
14. MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.
Yang Z; MacQuarrie KL; Analau E; Tyler AE; Dilworth FJ; Cao Y; Diede SJ; Tapscott SJ
Genes Dev; 2009 Mar; 23(6):694-707. PubMed ID: 19299559
[TBL] [Abstract][Full Text] [Related]
15. Human myostatin negatively regulates human myoblast growth and differentiation.
McFarlane C; Hui GZ; Amanda WZ; Lau HY; Lokireddy S; Xiaojia G; Mouly V; Butler-Browne G; Gluckman PD; Sharma M; Kambadur R
Am J Physiol Cell Physiol; 2011 Jul; 301(1):C195-203. PubMed ID: 21508334
[TBL] [Abstract][Full Text] [Related]
16. Expression of myogenic regulating factors, Myogenin and MyoD, in two canine botryoid rhabdomyosarcomas.
Kobayashi M; Sakai H; Hirata A; Yonemaru K; Yanai T; Watanabe K; Yamazoe K; Kudo T; Masegi T
Vet Pathol; 2004 May; 41(3):275-7. PubMed ID: 15133178
[TBL] [Abstract][Full Text] [Related]
17. CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG.
Liu Z; Zhang X; Lei H; Lam N; Carter S; Yockey O; Xu M; Mendoza A; Hernandez ER; Wei JS; Khan J; Yohe ME; Shern JF; Thiele CJ
Nat Commun; 2020 Feb; 11(1):911. PubMed ID: 32060262
[TBL] [Abstract][Full Text] [Related]
18. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD.
Bailey P; Downes M; Lau P; Harris J; Chen SL; Hamamori Y; Sartorelli V; Muscat GE
Mol Endocrinol; 1999 Jul; 13(7):1155-68. PubMed ID: 10406466
[TBL] [Abstract][Full Text] [Related]
19. Muscle-relevant genes marked by stable H3K4me2/3 profiles and enriched MyoD binding during myogenic differentiation.
Cui H; Bansal V; Grunert M; Malecova B; Dall'Agnese A; Latella L; Gatto S; Ryan T; Schulz K; Chen W; Dorn C; Puri PL; Sperling SR
PLoS One; 2017; 12(6):e0179464. PubMed ID: 28609469
[TBL] [Abstract][Full Text] [Related]
20. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.
Dodou E; Xu SM; Black BL
Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
